- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 263/46 - Sulfur atoms
Patent holdings for IPC class C07D 263/46
Total number of patents in this class: 74
10-year publication summary
3
|
3
|
7
|
11
|
9
|
8
|
4
|
9
|
2
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Novartis AG | 11224 |
10 |
North Carolina State University | 1537 |
6 |
Gwangju Institute of Science and Technology | 737 |
3 |
Industry-Academic Cooperation Foundation, Yonsei University | 2388 |
3 |
The Institute of Cancer Research: Royal Cancer Hospital | 184 |
3 |
IFM Tre, Inc. | 5 |
3 |
Merck Sharp & Dohme LLC | 3757 |
3 |
The General Hospital Corporation | 4666 |
2 |
Takeda Pharmaceutical Company Limited | 2940 |
2 |
Kyungpook National University Industry-Academic Cooperation Foundation | 1113 |
2 |
Regeneron Pharmaceuticals, Inc. | 4063 |
2 |
The Regents of the University of Colorado, a body corporate | 2545 |
2 |
Trustees of Dartmouth College | 1067 |
2 |
University of Pittsburgh - Of the Commonwealth System of Higher Education | 3065 |
2 |
Seoul National University R&db Foundation | 3358 |
2 |
PI Industries Ltd | 160 |
2 |
Novartis Inflammasome Research, Inc. | 10 |
2 |
Projini Agchem Ltd | 5 |
2 |
Merck Sharp & Dohme Corp. | 2213 |
1 |
Bayer Cropscience AG | 2128 |
1 |
Other owners | 19 |